Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Sexually Transmitted Infections|January 12, 2007
Modelling the cost-effectiveness of introducing rapid syphilis tests into an antenatal syphilis screening programme in Mwanza, TanzaniaP Vickerman, R W Peeling, F Terris-Prestholt, et al.
Sexually Transmitted Infections|March 25, 2009
Prevalence of HIV, HCV and sexually transmitted infections among injecting drug users in Rawalpindi and Abbottabad, Pakistan: evidence for an emerging injection-related HIV epidemicL Platt, P Vickerman, M Collumbien, et al.
AIDS and Behavior|August 14, 2012
Differences between seven measures of self-reported numbers of clients of female sex workers in southern India: implications for individual- and population-level analysisKathleen N Deering, P Vickerman, M Pickles, et al.
The Journal of Infection|September 28, 2022
Cost-effectiveness of pharmacy-led versus conventionally delivered antiviral treatment for hepatitis C in patients receiving opioid substitution therapy: An economic evaluation alongside a pragmatic cluster randomised trialG Myring, A G Lim, W Hollingworth, et al.
HIV Medicine|November 12, 2020
Is contact between men who have sex with men and non-governmental organizations providing harm reduction associated with improved HIV outcomes?A Trickey, J Stone, N Semchuk, et al.
European Journal of Public Health|April 8, 2009
Measuring risk of HIV and HCV among injecting drug users in the Russian FederationLucy Platt, A J Sutton, P Vickerman, et al.
Epidemiology and Infection|October 8, 2019
Clustering of hepatitis C virus antibody positivity within households and communities in Punjab, IndiaA Trickey, A Sood, V Midha, et al.
The International Journal on Drug Policy|January 13, 2024
Has the HCV cascade of care changed among people who inject drugs in England since the introduction of direct-acting antivirals?H D Gliddon, Z Ward, E Heinsbroek, et al.
Journal of Viral Hepatitis|March 31, 2016
New treatments for hepatitis C virus (HCV): scope for preventing liver disease and HCV transmission in EnglandR J Harris, N K Martin, E Rand, et al.
Journal of Clinical Microbiology|July 16, 1999
Performance of the Affymetrix GeneChip HIV PRT 440 platform for antiretroviral drug resistance genotyping of human immunodeficiency virus type 1 clades and viral isolates with length polymorphismsM Vahey, M E Nau, S Barrick, et al.
Pageof 3